Oncolytic Virus Immunotherapy Market Poised to Reach $5B by 2031
Global oncolytic virus immunotherapy market projected to exceed $5 billion by 2031, driven by three approved therapies and 150+ clinical candidates advancing combination approaches.
BMYCELGrMRKRHHBYREPL+1clinical trialscancer treatment